Cargando…
Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial
PURPOSE: To prospectively evaluate interobserver agreement for small bowel ultrasound (SBUS) in newly diagnosed and relapsing Crohn’s disease. METHODS: A subset of patients recruited to a prospective trial comparing the diagnostic accuracy of MR enterography and SBUS underwent a second SBUS performe...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455580/ https://www.ncbi.nlm.nih.gov/pubmed/32037466 http://dx.doi.org/10.1007/s00261-020-02405-w |
_version_ | 1783575656706080768 |
---|---|
author | Bhatnagar, Gauraang Quinn, Laura Higginson, Antony Plumb, Andrew Halligan, Steve Tolan, Damian Lapham, Roger Mallett, Susan Taylor, Stuart A. |
author_facet | Bhatnagar, Gauraang Quinn, Laura Higginson, Antony Plumb, Andrew Halligan, Steve Tolan, Damian Lapham, Roger Mallett, Susan Taylor, Stuart A. |
author_sort | Bhatnagar, Gauraang |
collection | PubMed |
description | PURPOSE: To prospectively evaluate interobserver agreement for small bowel ultrasound (SBUS) in newly diagnosed and relapsing Crohn’s disease. METHODS: A subset of patients recruited to a prospective trial comparing the diagnostic accuracy of MR enterography and SBUS underwent a second SBUS performed by one of a pool of six practitioners, who recorded the presence, activity and location of small bowel and colonic disease. Detailed segmental mural and extra-mural observations were also scored. Interobserver variability was expressed as percentage agreement with a construct reference standard, split by patient cohort, grouping disease as present or absent. Prevalence adjusted bias adjusted kappa (PABAK), and simple percentage agreement between practitioners, irrespective of the reference standard, were calculated. RESULTS: Thirty-eight patients (11 new diagnosis, 27 relapse) were recruited from two sites. Overall percentage agreement for small bowel disease presence against the consensus reference was 82% (52–95% (95%CI)), kappa coefficient (κ) 0.64, (substantial agreement) for new diagnosis and 81%, κ 0.63 (substantial agreement) for the relapsing cohort. Agreement for colonic disease presence was 64%, κ 0.27 (fair agreement) in new diagnosis and 78%,κ 0.56 (moderate agreement) in the relapsing cohort. Simple agreement between practitioners was 84% and 87% for small bowel and colonic disease presence respectively. Practitioners agreed on small bowel disease activity in 24/27 (89%) where both identified disease. Kappa agreement for detailed mural observations ranged from κ 0.00 to 1.00. CONCLUSION: There is substantial practitioner agreement for small bowel disease presence in newly diagnosed and relapsing CD patients, supporting wider dissemination of enteric US. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00261-020-02405-w) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7455580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-74555802020-09-03 Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial Bhatnagar, Gauraang Quinn, Laura Higginson, Antony Plumb, Andrew Halligan, Steve Tolan, Damian Lapham, Roger Mallett, Susan Taylor, Stuart A. Abdom Radiol (NY) Hollow Organ GI PURPOSE: To prospectively evaluate interobserver agreement for small bowel ultrasound (SBUS) in newly diagnosed and relapsing Crohn’s disease. METHODS: A subset of patients recruited to a prospective trial comparing the diagnostic accuracy of MR enterography and SBUS underwent a second SBUS performed by one of a pool of six practitioners, who recorded the presence, activity and location of small bowel and colonic disease. Detailed segmental mural and extra-mural observations were also scored. Interobserver variability was expressed as percentage agreement with a construct reference standard, split by patient cohort, grouping disease as present or absent. Prevalence adjusted bias adjusted kappa (PABAK), and simple percentage agreement between practitioners, irrespective of the reference standard, were calculated. RESULTS: Thirty-eight patients (11 new diagnosis, 27 relapse) were recruited from two sites. Overall percentage agreement for small bowel disease presence against the consensus reference was 82% (52–95% (95%CI)), kappa coefficient (κ) 0.64, (substantial agreement) for new diagnosis and 81%, κ 0.63 (substantial agreement) for the relapsing cohort. Agreement for colonic disease presence was 64%, κ 0.27 (fair agreement) in new diagnosis and 78%,κ 0.56 (moderate agreement) in the relapsing cohort. Simple agreement between practitioners was 84% and 87% for small bowel and colonic disease presence respectively. Practitioners agreed on small bowel disease activity in 24/27 (89%) where both identified disease. Kappa agreement for detailed mural observations ranged from κ 0.00 to 1.00. CONCLUSION: There is substantial practitioner agreement for small bowel disease presence in newly diagnosed and relapsing CD patients, supporting wider dissemination of enteric US. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00261-020-02405-w) contains supplementary material, which is available to authorized users. Springer US 2020-02-10 2020 /pmc/articles/PMC7455580/ /pubmed/32037466 http://dx.doi.org/10.1007/s00261-020-02405-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Hollow Organ GI Bhatnagar, Gauraang Quinn, Laura Higginson, Antony Plumb, Andrew Halligan, Steve Tolan, Damian Lapham, Roger Mallett, Susan Taylor, Stuart A. Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial |
title | Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial |
title_full | Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial |
title_fullStr | Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial |
title_full_unstemmed | Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial |
title_short | Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial |
title_sort | observer agreement for small bowel ultrasound in crohn’s disease: results from the metric trial |
topic | Hollow Organ GI |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455580/ https://www.ncbi.nlm.nih.gov/pubmed/32037466 http://dx.doi.org/10.1007/s00261-020-02405-w |
work_keys_str_mv | AT bhatnagargauraang observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial AT quinnlaura observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial AT higginsonantony observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial AT plumbandrew observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial AT halligansteve observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial AT tolandamian observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial AT laphamroger observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial AT mallettsusan observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial AT taylorstuarta observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial AT observeragreementforsmallbowelultrasoundincrohnsdiseaseresultsfromthemetrictrial |